Susquehanna International Group’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.1M | Buy |
852,820
+688,608
| +419% | +$16.4M | ﹤0.01% | 2158 |
|
|
2025
Q4 | $3.83M | Buy |
164,212
+97,224
| +145% | +$2.17M | ﹤0.01% | 4470 |
|
|
2025
Q3 | $1.32M | Sell |
66,988
-203,183
| -75% | -$4.18M | ﹤0.01% | 6672 |
|
|
2025
Q2 | $5.86M | Buy |
270,171
+34,299
| +15% | +$810K | ﹤0.01% | 3680 |
|
|
2025
Q1 | $5.72M | Buy |
235,872
+136,659
| +138% | +$3.08M | ﹤0.01% | 3401 |
|
|
2024
Q4 | $2.07M | Sell |
99,213
-22,009
| -18% | -$473K | ﹤0.01% | 5241 |
|
|
2024
Q3 | $2.41M | Buy |
121,222
+36,246
| +43% | +$672K | ﹤0.01% | 4925 |
|
|
2024
Q2 | $1.32M | Sell |
84,976
-44,125
| -34% | -$687K | ﹤0.01% | 5946 |
|
|
2024
Q1 | $2.06M | Sell |
129,101
-53,442
| -29% | -$805K | ﹤0.01% | 5267 |
|
|
2023
Q4 | $3.07M | Buy |
182,543
+46,571
| +34% | +$637K | ﹤0.01% | 4532 |
|
|
2023
Q3 | $1.59M | Sell |
135,972
-52,702
| -28% | -$705K | ﹤0.01% | 5607 |
|
|
2023
Q2 | $2.54M | Sell |
188,674
-6,427
| -3% | -$92.5K | ﹤0.01% | 4668 |
|
|
2023
Q1 | $3.23M | Sell |
195,101
-94,174
| -33% | -$1.55M | ﹤0.01% | 4178 |
|
|
2022
Q4 | $5.38M | Buy |
289,275
+74,645
| +35% | +$1.15M | ﹤0.01% | 3129 |
|
|
2022
Q3 | $2.75M | Buy |
214,630
+155,039
| +260% | +$1.84M | ﹤0.01% | 4250 |
|
|
2022
Q2 | $418K | Sell |
59,591
-51,919
| -47% | -$381K | ﹤0.01% | 8712 |
|
|
2022
Q1 | $924K | Sell |
111,510
-55,941
| -33% | -$395K | ﹤0.01% | 7328 |
|
|
2021
Q4 | $1.13M | Sell |
167,451
-26,959
| -14% | -$177K | ﹤0.01% | 6958 |
|
|
2021
Q3 | $1.03M | Sell |
194,410
-112,096
| -37% | -$613K | ﹤0.01% | 7480 |
|
|
2021
Q2 | $1.76M | Buy |
306,506
+137,826
| +82% | +$711K | ﹤0.01% | 6208 |
|
|
2021
Q1 | $778K | Buy |
168,680
+67,034
| +66% | +$266K | ﹤0.01% | 8379 |
|
|
2020
Q4 | $339K | Buy |
101,646
+6,545
| +7% | +$22K | ﹤0.01% | 9031 |
|
|
2020
Q3 | $282K | Buy |
95,101
+52,670
| +124% | +$206K | ﹤0.01% | 8839 |
|
|
2020
Q2 | $196K | Sell |
42,431
-127,479
| -75% | -$573K | ﹤0.01% | 9054 |
|
|
2020
Q1 | $654K | Sell |
169,910
-25,353
| -13% | -$104K | ﹤0.01% | 6356 |
|
|
2019
Q4 | $732K | Sell |
195,263
-128,271
| -40% | -$600K | ﹤0.01% | 6164 |
|
|
2019
Q3 | $1.72M | Buy |
323,534
+173,658
| +116% | +$925K | ﹤0.01% | 4530 |
|
|
2019
Q2 | $576K | Buy |
+149,876
| New | +$647K | ﹤0.01% | 6982 |
|
|
2019
Q1 | – | Sell |
-47,578
| Closed | -$140K | – | 8935 |
|
|
2018
Q4 | $91K | Buy |
+47,578
| New | +$136K | ﹤0.01% | 8258 |
|
|
2018
Q3 | – | Sell |
-12,695
| Closed | -$39.8K | – | 9319 |
|
|
2018
Q2 | $40K | Buy |
+12,695
| New | +$38.5K | ﹤0.01% | 9320 |
|
|
2018
Q1 | – | Sell |
-35,994
| Closed | -$120K | – | 9404 |
|
|
2017
Q4 | $141K | Buy |
+35,994
| New | +$119K | ﹤0.01% | 8521 |
|
|
2017
Q1 | – | Sell |
-59,541
| Closed | -$63K | – | 9041 |
|
|
2016
Q4 | $63K | Sell |
59,541
-20,956
| -26% | -$23.9K | ﹤0.01% | 9231 |
|
|
2016
Q3 | $88K | Sell |
80,497
-31,813
| -28% | -$28.6K | ﹤0.01% | 7986 |
|
|
2016
Q2 | $80K | Buy |
112,310
+80,480
| +253% | +$64.8K | ﹤0.01% | 8118 |
|
|
2016
Q1 | $38K | Buy |
31,830
+6,041
| +23% | +$9.37K | ﹤0.01% | 8719 |
|
|
2015
Q4 | $63K | Buy |
25,789
+2,266
| +10% | +$6.49K | ﹤0.01% | 9047 |
|
|
2015
Q3 | $71K | Sell |
23,523
-5,971
| -20% | -$25.8K | ﹤0.01% | 9276 |
|
|
2015
Q2 | $122K | Sell |
29,494
-315,260
| -91% | -$1.26M | ﹤0.01% | 9591 |
|
|
2015
Q1 | $1.49M | Buy |
344,754
+277,897
| +416% | +$1M | ﹤0.01% | 4924 |
|
|
2014
Q4 | $199K | Buy |
66,857
+51,562
| +337% | +$141K | ﹤0.01% | 8830 |
|
|
2014
Q3 | $51K | Sell |
15,295
-92,638
| -86% | -$242K | ﹤0.01% | 9217 |
|
|
2014
Q2 | $273K | Buy |
+107,933
| New | +$231K | ﹤0.01% | 8542 |
|
Other funds holding CPRX
VCM
DM
VPM